Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Recent advances in the management of gastrointestinal stromal tumors
Margaret von Mehren
Cancer Epigenetics Institute
Cancer Signaling and Microenvironment (CSM)
Hematology Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recent advances in the management of gastrointestinal stromal tumors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Neoplasm
100%
Gastrointestinal Stromal Tumor
100%
Imatinib
100%
Patient
75%
Therapeutic Procedure
50%
Disease
25%
Gene
25%
Clinical Trial
25%
Growth
25%
Chemotherapeutic Agent
25%
Drug
25%
Protein
25%
Primary Tumor
25%
Growth Factor Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Gastrointestinal Stromal Tumor
100%
Imatinib
100%
Protein
25%
Diseases
25%
Drug
25%
Primary Tumor
25%
Growth Factor Receptor
25%
Biochemistry, Genetics and Molecular Biology
Imatinib
100%
Mutation
25%
Nested Gene
25%
Protein
25%
Growth
25%
Wild Type
25%
Methanesulfonic Acid
25%
Growth Factor Receptor
25%